We are delighted to announce the signing of a strategic partnership between NIPD Genetics and Medicover, a leading international healthcare and diagnostic services company. The partnership includes a substantial investment to boost NIPD Genetics’ research and development of new tests, and enhance sales, marketing and customer service.

Medicover will introduce VERACITY and VERAGENE through their international sales network of clinics, hospitals and laboratories. Medicover will also support NIPD Genetics on designing and developing new genetic tests in prenatal, postnatal, neonatal, oncology and transplantation fields.

Please see the press release for more information regarding the partnership. For more information email us at info@nipd.com.